A pen needle (531) includes a hub (511) and a needle (513) fixedly connected to the hub (511). An outer cover (501) receives the hub (511). A lubricant reservoir (503) is disposed in the outer cover (501) such that a portion of the needle (513) is disposed in the lubricant reservoir (503) when the hub (511) is received by the outer cover (501). Lubrication of the needle (513) facilitates multiple injections.

Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In some embodiments, the self-righting article may comprise a tissue interfacing component and/or a pharmaceutical agent (e.g., for delivery of the active pharmaceutical agent to a location internal of the subject). In some cases, upon contact of the tissue with the tissue engaging surface of the article, the self-righting article may be configured to release one or more tissue interfacing components. In some cases, the tissue interfacing component is associated with a self-actuating component. For example, the self-righting article may comprise a self-actuating component configured, upon exposure to a fluid, to release the tissue interfacing component from the self-righting article. In some cases, the tissue interfacing component may comprise and/or be associated with the pharmaceutical agent (e.g., for delivery to a location internal to a subject).

A syringe assembly for administration of a neurotoxin, the syringe assembly comprising: a syringe comprising: a clear syringe barrel with dosage markings completely encircling the clear syringe barrel; and a plunger having a plunger body and a clear inverted plunger tip; and a needle assembly comprising a needle and a sealing hub for removably attaching the needle assembly to the syringe, wherein the needle is approximately 0.15 inches to approximately 0.3 inches in length and has a gauge of approximately 27 gauge to approximately 35 gauge.

Provided is a microsyringe unit capable of improving the accuracy of the injection position of liquid in a brain. The microsyringe unit of the present invention is composed of a microsyringe (100) and a needle guide (200). The microsyringe (100) includes a cylindrical needle (110), a plunger (120) that is passed through the needle (110), and a needle base portion (130) that supports the needle (110). The needle base portion (130) abuts on a guide base portion (230) of the needle guide (200), thereby causing a part of the needle (110) to protrude from the tip of the needle guide (200) in a reference state in which forward movement of the needle (110) passed through the needle guide (200) is stopped.

A needle tube having a needle tip for puncturing skin; a needle hub; and a fluid-draining portion for enabling draining of a medicine. The needle hub includes: a retention part (first member) for retaining the needle tube; an insertion part into which the output portion of a syringe is inserted; and a flange-like skin contact portion that is disposed in a manner so as to cover an area surrounding the needle tube and makes contact with and/or faces the skin when a living body is punctured with the needle tube. The fluid-draining portion is disposed in the skin contact portion of the needle hub and enables a user to drain the medicine that has spilled when removing air and is held in the skin contact portion.

A catheter assembly may include a cannula. The cannula may include a distal tip, an elongated tubular shaft, and an inner lumen formed by the elongated tubular shaft. A first portion of the elongated tubular shaft may have a first outer diameter. The first portion may be proximate the distal tip. A second portion of the elongated tubular shaft may have a second outer diameter. The second outer diameter may be greater than the first outer diameter. The catheter assembly may also include a catheter adapter, which may include a catheter and a catheter hub. The second portion of the elongated tubular shaft may be at least partially disposed in the catheter hub.

The present disclosure relates to a medicament injection device comprising a housing, a cartridge holder mounted in the housing and configured to receive a cartridge containing a medicament, an injection needle having a proximal end and a distal end, an injection needle holder to which the injection needle is fixed. The medicament injection device comprises an actuating mechanism for pivoting the injection needle holder relative to the cartridge holder between a storage position in which, when the cartridge is received in the cartridge holder, the distal end of the injection needle is spaced from the cartridge, and a use position in which, when the cartridge is received in the cartridge holder, the distal end of the injection needle can engage the cartridge.

A medical device such as a needle subassembly is disclosed including a cover over a magnetized portion of a tissue-penetrating medical device having a shielding material associated with the cover that prevents the magnetized portion of the tissue-penetrating medical device from being de-magnetized when the cover is positioned to cover the tissue-penetrating medical device.

A medical device may include a needle, including a plurality of links and a distal tip, reciprocally movable between a first configuration and a second configuration, and a conduit including a lumen extending through the needle, the conduit being coupled to the distal tip, wherein longitudinal movement of the conduit is configured to transition the needle between the first configuration and the second configuration.

The present disclosure relates generally to depot formulations of lurasidone and methods of making depot formulations of lurasidone. The depot formulations include a suspending agent and are highly syringeable.